Neonatology · 1998 · 37 citations · 9 references
MedicineCardiologyPediatricsNeonatal HealthNeonatologyPediatric CardiologyCardiac BiomarkersNeonatal Cardiac DisordersNeonatal CardiologyPediatric EchocardiographyBiochemical Screening MarkersControl Group DesignMatched Control GroupMyocardial Injury MarkersNeonatal Cardiac BiomarkersTroponin ElevationTroponin Release
The measurement of myocardial damage by newer, highly specific markers of myocardial damage is now possible, including cardiac structural proteins such as troponin T (TnT). In neonates of pre-eclamptic mothers, it identifies minor myocardial damage missed by other biochemical markers. The present study was designed to determine the diagnostic value of TnT concentrations in neonates of pre-eclamptic mothers. Fifteen neonates of pre-eclamptic mothers were studied (9 boys and 6 girls), and 17 healthy full-term neonates (9 boys and 8 girls) were selected as a control group. The serum TnT concentration in neonates of pre-eclamptic mothers (0.70 ng/ml) was significantly higher than that in the control group (0.10 ng/ml). In an echocardiographic study, the mean mitral peak velocity at an atrial contraction (A) value of 39 cm/s in neonates of pre-eclamptic mothers was significantly lower than that in the control group (53 cm/s), and the mean mitral peak velocity of early diastole to peak velocity of the atrial contraction (E/A) value (1.75) in neonates of pre-eclamptic mothers was significantly higher than that in the control subjects (1.23). In conclusion, our study demonstrated high levels of cardiac TnT, lower mitral A values and high mitral E/A values in neonates of pre-eclamptic mothers, presumably associated with mild myocardial damage in the neonates of pre-eclamptic mothers.
9
Cardiac troponin I. A marker with high specificity for cardiac injury.
Jesse E. Adams, G. Bodor, Víctor G. Dávila‐Román et al. · Circulation · 1993 · 1.2K citations · Full text